Jim Cramer: Healthpeak Properties Is A 'Reasonable' REIT, Recommends Buying This Health Care Stock

On CNBC's “Mad Money Lightning Round,” Jim Cramer recommended buying GRAIL, Inc. GRAL, adding that he likes the stock a lot.

Supporting his view, Morgan Stanley analyst Tejas Savant, on March 18, raised the price target on the stock from $16 to $20.

“That' like a dice roll,” Cramer said when asked about Turkcell Iletisim Hizmetleri A.S. TKC. “That's a bridge too far for me.”

On the earnings front, Turkcell, on Feb. 27, posted an FY net profit of 23.52 billion Lira versus a year-ago profit of 18.13 billion Lira.

When asked about Block, Inc. XYZ, he said, “I'm going to say buy half right now, and then if it breaks down below 53, then you can buy more.”

Keefe, Bruyette & Woods analyst Vasundhara Govil, on March 18, upgraded Block from Market Perform to Outperform but lowered the price target from $87 to $80.

Healthpeak Properties, Inc. DOC is a “reasonable” REIT, Cramer said.

On Feb. 28, Scotiabank analyst Nicholas Yulico maintained Healthpeak Properties with a Sector Outperform and lowered the price target from $24 to $23.

The Mad Money host said Rubrik, Inc. RBRK is doing “very, very well.”

As per the recent news, NTT DATA partnered with Rubrik on Monday for cybersecurity ransomware protection.

Cramer said Edwards Lifesciences Corporation EW is a hold and prefers Boston Scientific Corporation BSX to Edwards Lifesciences.

On the earnings front, Edwards Lifesciences, on Feb. 11, posted better-than-expected quarterly earnings.

“We have to wait another quarter,” Cramer said when asked about Shake Shack Inc. SHAK.

Wells Fargo analyst Anthony Trainor, on Wednesday, initiated coverage on Shake Shack with an Equal-Weight rating and announced a price target of $95.

TransMedics Group, Inc. TMDX is an “interesting” company, Cramer said. “I'm not going to necessarily recommend it right here.”

Needham analyst Mike Matson reiterated TransMedics Group with a Hold rating on Wednesday.

“It's never been this cheap that I can recall,” Cramer said when asked about Arista Networks Inc ANET. “Here's the problem, it's a data center stock.”

On March 5, UBS analyst David Vogt upgraded Arista Networks from Neutral to Buy and raised the price target from $112 to $115.

Price Action:

Turkcell Iletisim Hizmetleri shares fell 2.3% to settle at $6.08 on Thursday.

GRAIL shares gained 0.7% to close at $28.58 during the session.

Arista Networks’ shares fell 3.3% to settle at $78.96.

Shake Shack shares rose 0.3% to settle at $93.62.

TransMedics Group shares gained 0.2% to close at $70.44.

Rubrik shares fell 3.8% to settle at $66.00.

Edwards Lifesciences’ shares rose 0.1% to close at $71.19.

Block shares fell 3.5% to settle at $56.99 on Thursday.

Healthpeak Properties shares fell 0.4% to close at $20.22.

Now Read: